E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
The development comes as Zydus continues to expand its portfolio of generic medicines in the US market.
imphoenix82
Speaking to Health Xplore on the sidelines of iPHEX 2026, Dr Shipra Pandey, Deputy Manager – International Business Development, Ratnatris Pharmaceuticals, discusses the company’s international expansion plans, expectations of foreign buyers, India’s dependence on Chinese APIs, and more.
dineshwori
The transfer was executed on a slump sale basis in accordance with the Business Transfer Agreement (BTA) signed between Aurobindo Pharma and Auropharm.
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
